<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pulmonary involvement in AIDS-related Kaposi sarcoma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pulmonary involvement in AIDS-related Kaposi sarcoma</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pulmonary involvement in AIDS-related Kaposi sarcoma</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kevin R Flaherty, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David M Aboulafia, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sonali M Shah, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>AIDS-related Kaposi sarcoma (KS) is a low-grade vascular tumor associated with human herpesvirus 8 (HHV-8), which is also known as the Kaposi sarcoma-associated herpesvirus (KSHV). HHV-8 is also causally linked to primary effusion lymphoma and multicentric Castleman’s disease. The widespread application of potent combination antiretroviral therapy (ART) has led to a striking decrease in the incidence of KS and has changed its natural history [<a href="#rid1">1</a>].</p><p>The clinical manifestations, diagnosis, and complications of pulmonary AIDS-associated KS are discussed here. Other aspects of AIDS-related KS are reviewed separately. (See  <a class="medical medical_review" href="/d/html/8033.html" rel="external">"AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment"</a> and  <a class="medical medical_review" href="/d/html/8319.html" rel="external">"Human herpesvirus-8 infection"</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>In 80 to 90 percent of cases, pulmonary involvement with KS occurs in conjunction with more extensive mucocutaneous disease [<a href="#rid2">2,3</a>]. However, pulmonary involvement can be the initial manifestation of KS and occurs in the absence of mucocutaneous disease in 15 percent [<a href="#rid4">4</a>].</p><p>Pulmonary KS can involve the lung parenchyma, airways, pleura, and/or intrathoracic lymph nodes. There are no unique manifestations that distinguish KS from other pathologic processes in the lungs.</p><p class="bulletIndent1"><span class="glyph">●</span>Parenchymal lung involvement is usually manifest clinically by dyspnea, hypoxemia, and dry cough developing over a few weeks [<a href="#rid5">5</a>]. Hemoptysis, fever, fatigue and occasionally respiratory failure can also occur.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endobronchial KS may be asymptomatic; however, intractable cough, hemoptysis, wheezing, upper airway obstruction, and atelectasis may occur.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pleural effusions are radiographically visualized in up to two-thirds of patients with parenchymal KS and occasionally may occur as an isolated manifestation of KS. However, large, difficult to manage pleural effusions are much less common since the introduction of antiretroviral therapy (ART). (See  <a class="medical medical_review" href="/d/html/6693.html" rel="external">"Pleural effusions in HIV-infected patients", section on 'Kaposi sarcoma'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enlarged mediastinal nodes are frequent in patients with pulmonary KS although the cause of the lymphadenopathy is often unclear. Adenopathy in patients suspected to have pulmonary KS is important because of the need to identify other diseases that can cause adenopathy, including opportunistic infections and other tumors.</p><p></p><p>Rapid progression of pulmonary KS can be precipitated by systemic glucocorticoids, which are often used to treat other conditions in HIV infected patients. Thus, the possibility of pulmonary KS should be considered when pulmonary symptoms develop following the initiation of glucocorticoid therapy.</p><p>When evaluating a patient for possible pulmonary KS, a careful skin and mucous membrane exam is essential [<a href="#rid2">2,3</a>]. Cutaneous KS lesions are typically found on the lower extremities, tip of the nose, and genitalia, but may be widespread  (<a class="graphic graphic_picture graphicRef70919" href="/d/graphic/70919.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef83857" href="/d/graphic/83857.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef61561" href="/d/graphic/61561.html" rel="external">picture 3</a> and <a class="graphic graphic_picture graphicRef52327" href="/d/graphic/52327.html" rel="external">picture 4</a>). (See  <a class="medical medical_review" href="/d/html/8033.html" rel="external">"AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis", section on 'Cutaneous KS'</a>.)</p><p class="headingAnchor" id="H793198"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>Patients with known mucocutaneous KS have a higher likelihood of lung involvement with KS, but still need a careful evaluation of any new pulmonary symptoms or findings to identify other infections or malignancies. The evaluation of pulmonary symptoms in patients with HIV infection typically involves a combination of assessing the degree of immune compromise, imaging to ascertain the pattern and extent of lung, pleural, and mediastinal disease, thoracentesis if a pleural effusion is present, and often performing flexible bronchoscopy to obtain samples for immunoassay, stains, culture, and cytology. (See  <a class="medical medical_review" href="/d/html/3721.html" rel="external">"Evaluation of pulmonary symptoms in persons with HIV"</a>.)</p><p class="headingAnchor" id="H793270"><span class="h2">Laboratory</span><span class="headingEndMark"> — </span>When a new diagnosis of KS is suspected in a patient with HIV infection, the degree of HIV-related immunosuppression is assessed by measuring the CD4 count and HIV viral load. Patients with KS typically have a low CD4 cell count (&lt;150 cells per cubic millimeter) and a high HIV viral load (&gt;10,000 copies per milliliter). (See  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment", section on 'Staging and evaluation'</a>.)</p><p class="headingAnchor" id="H793278"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>A conventional chest radiograph is part of the initial evaluation of respiratory symptoms in patients with HIV/AIDS. KS typically involves the lung parenchyma in one of two patterns on chest radiographs:</p><p class="bulletIndent1"><span class="glyph">●</span>Tumor infiltrating the septae presents radiographically as patchy reticular opacities that frequently occur in a peribronchovascular distribution. This pattern is seen in approximately 60 percent of cases [<a href="#rid6">6-9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ill-defined nodular densities are also common, occurring in approximately 25 percent of chest radiographs [<a href="#rid8">8-11</a>].</p><p></p><p>Overlap radiographic patterns, areas of focal consolidation, a solitary nodule, coalescence of nodules, and normal radiographs can also be seen in some patients [<a href="#rid6">6,7,12,13</a>].</p><p>Computed tomography (CT) of the chest is typically obtained to evaluate abnormalities noted on chest radiograph or pulmonary function tests. In addition, CT is useful to evaluate hemoptysis in patients with a normal chest radiograph.</p><p>Two findings on chest CT are highly suggestive of parenchymal KS: hilar densities extending into the parenchyma along perivascular or peribronchial pathways and a characteristic septal or nodular pattern with concomitant pleural effusions [<a href="#rid8">8,14-16</a>]. Correlation between pathology and imaging has shown that central peribronchovascular opacities represent tumor growth involving the bronchovascular bundles, while nodules correspond to proliferations of neoplastic cells in the lung parenchyma [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H792755"><span class="h2">Bronchoscopy</span><span class="headingEndMark"> — </span>Bronchoscopy and bronchoalveolar lavage (BAL) are often performed in HIV-infected patients with pulmonary symptoms and parenchymal abnormalities on chest radiograph or chest CT scan. The main purposes are to examine the airways for endobronchial KS lesions and to obtain BAL samples for microbiologic stains and culture, immunoassays for infectious agents, and cytologic examination for viral inclusions or tumors other than KS. The diagnosis of KS cannot be made from cytologic specimens, as biopsy specimen is needed to see the characteristic architecture of spindle cells surrounding thin vascular channels. (See  <a class="medical medical_review" href="/d/html/3721.html" rel="external">"Evaluation of pulmonary symptoms in persons with HIV"</a>.)</p><p>Endobronchial KS lesions typically appear violaceous or bright red and are macular or papular  (<a class="graphic graphic_picture graphicRef87393" href="/d/graphic/87393.html" rel="external">picture 5</a>). Common sites include the mucosa of the lower airways, especially at branching points, or, less commonly, in the trachea  (<a class="graphic graphic_picture graphicRef70662" href="/d/graphic/70662.html" rel="external">picture 6</a> and <a class="graphic graphic_picture graphicRef76580 graphicRef78341" href="/d/graphic/76580.html" rel="external">picture 7A-B</a>) [<a href="#rid12">12,18</a>]. Bacillary angiomatosis can also cause violaceous endobronchial mucosal lesions, but these lesions are typically raised or polypoid, while those of KS are typically flat.</p><p>Endobronchial and transbronchial biopsies have a low diagnostic yield for KS [<a href="#rid10">10,12,19</a>], although the occasional biopsy is positive  (<a class="graphic graphic_picture graphicRef77671" href="/d/graphic/77671.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef81327" href="/d/graphic/81327.html" rel="external">picture 9</a> and <a class="graphic graphic_picture graphicRef78341" href="/d/graphic/78341.html" rel="external">picture 7B</a>). We avoid performing transbronchial biopsies when KS is thought to be likely, as significant hemorrhage has occurred following biopsy of KS lesions in up to 30 percent of patients [<a href="#rid12">12,20</a>].</p><p class="headingAnchor" id="H2891823"><span class="h2">Thoracentesis and pleural biopsy</span><span class="headingEndMark"> — </span>The main roles for thoracentesis and pleural biopsy in evaluating pleural KS are to exclude infection or other causes of malignant effusions (eg, multicentric Castleman’s disease, non-Hodgkin lymphoma, primary effusion lymphoma, lung cancer)  (<a class="graphic graphic_table graphicRef58777" href="/d/graphic/58777.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef71626" href="/d/graphic/71626.html" rel="external">table 2</a>). Thoracentesis may also be useful to relieve dyspnea when an effusion is large. (See  <a class="medical medical_review" href="/d/html/6693.html" rel="external">"Pleural effusions in HIV-infected patients"</a>.)</p><p>KS lesions are found on the visceral but not parietal pleura, so closed pleural biopsy is not useful for detecting pleural KS. On the other hand, closed pleural biopsy is often helpful in the diagnosis of pleural infections such as mycobacterial disease. Biopsy samples are sent for special stains, routine and mycobacterial culture, and pathology.</p><p>Video-assisted thoracoscopy is sometimes performed to evaluate an undiagnosed pleural effusion. During thoracoscopy, violaceous patchy lesions of KS may be seen on the visceral pleural surface.</p><p class="headingAnchor" id="H4180968"><span class="h2">Pathology</span><span class="headingEndMark"> — </span>The microscopic features of KS lesions include angiogenesis, inflammation, and spindle cell proliferation  (<a class="graphic graphic_picture graphicRef77671" href="/d/graphic/77671.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef81327" href="/d/graphic/81327.html" rel="external">picture 9</a> and <a class="graphic graphic_picture graphicRef78341" href="/d/graphic/78341.html" rel="external">picture 7B</a> and <a class="graphic graphic_picture graphicRef76580" href="/d/graphic/76580.html" rel="external">picture 7A</a>). Spindle cells consistently stain for CD34 and commonly CD31 but are factor VIII negative. Polymerase chain reaction to detect amplified human herpesvirus 8 (HHV-8) DNA sequences and immunohistochemical staining for HHV-8 antigen can be performed on biopsy specimens to confirm the diagnosis. (See  <a class="medical medical_review" href="/d/html/7726.html" rel="external">"Classic Kaposi sarcoma: Epidemiology, risk factors, pathology, and molecular pathogenesis", section on 'Pathology'</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The presumptive diagnosis of AIDS-related pulmonary KS is often clinical, based on features such as the epidemiology (eg, geographic location, people who engage in unprotected anal intercourse), presence of mucocutaneous KS lesions, degree of immunodeficiency, radiographic appearance, appearance of endobronchial lesions, and exclusion of other infectious or neoplastic processes.</p><p class="headingAnchor" id="H10"><span class="h2">Pulmonary parenchymal and endobronchial disease</span><span class="headingEndMark"> — </span>The diagnostic evaluation of suspected parenchymal pulmonary KS requires bronchoscopy to look for endobronchial lesions typical of KS and to exclude intercurrent infection. The diagnosis is confirmed when:</p><p class="bulletIndent1"><span class="glyph">●</span>Endobronchial lesions characteristic of KS are identified by bronchoscopy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The clinical and radiographic findings are suggestive of parenchymal pulmonary KS and an infectious etiology has been excluded</p><p></p><p>Although a tissue diagnosis is not required to establish the diagnosis of pulmonary KS, open lung biopsy may be necessary if the clinical, radiographic, and/or bronchoscopic picture is atypical. When tissue is obtained, the diagnosis is confirmed by finding the typical pathologic features of angiogenesis, inflammation, and spindle cell proliferation, in addition to positive polymerase chain reaction or immunoassay for human herpesvirus 8 (HHV-8). (See <a class="local">'Pathology'</a> above.)</p><p class="headingAnchor" id="H793510"><span class="h2">Pleural disease</span><span class="headingEndMark"> — </span>Establishing the diagnosis of pleural KS in the absence of lung or airway KS is difficult. Pleural fluid cytology and pleural biopsies are not helpful in documenting KS, but they may be useful for excluding other processes (eg, infection, lymphoma). In cases of rapidly recurrent pleural effusion accumulation, alternative diagnoses (eg, pleural effusion lymphoma) should be entertained. The diagnosis and differential diagnosis of pleural KS are described separately. (See  <a class="medical medical_review" href="/d/html/6693.html" rel="external">"Pleural effusions in HIV-infected patients", section on 'Kaposi sarcoma'</a>.)</p><p class="headingAnchor" id="H714289"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Patients with AIDS may have pulmonary symptoms due to parenchymal or pleural disease to a wide range of infectious and neoplastic processes. Given the time course of onset of symptoms in pulmonary KS, infections due to atypical bacteria (eg, Bartonella), mycobacteria, and fungi are particularly important in the differential diagnosis. The differential diagnosis and an approach to their evaluation are discussed separately. (See  <a class="medical medical_review" href="/d/html/3721.html" rel="external">"Evaluation of pulmonary symptoms in persons with HIV"</a> and  <a class="medical medical_review" href="/d/html/6693.html" rel="external">"Pleural effusions in HIV-infected patients"</a>.)</p><p>Neoplastic diseases in the differential of KS lung and pleural involvement include pulmonary lymphoma, primary effusion lymphoma, multicentric Castleman’s disease (also associated with HHV-8), and lung cancer, which is significantly more common in those with HIV infection compared with the general population. (See  <a class="medical medical_review" href="/d/html/4752.html" rel="external">"Primary effusion lymphoma"</a> and  <a class="medical medical_review" href="/d/html/4707.html" rel="external">"HHV-8/KSHV-associated multicentric Castleman disease"</a> and  <a class="medical medical_review" href="/d/html/6693.html" rel="external">"Pleural effusions in HIV-infected patients", section on 'Malignant effusions'</a> and  <a class="medical medical_review" href="/d/html/8036.html" rel="external">"HIV infection and malignancy: Management considerations", section on 'Lung cancer'</a> and  <a class="medical medical_review" href="/d/html/4750.html" rel="external">"HIV-related lymphomas: Clinical manifestations and diagnosis", section on 'Lung and pleura'</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H13609141"><span class="h2">Systemic treatment</span><span class="headingEndMark"> — </span>The mainstay of treatment of pulmonary KS is antiretroviral therapy (ART). Prior to the introduction of potent ART, pulmonary AIDS-related KS was associated with a very poor prognosis, with median survivals of 2 to 10 months in various reports [<a href="#rid12">12,21,22</a>]. However, the use of ART in this patient population has significantly altered the natural history of KS as well as decreasing the incidence of this disease. (See <a class="local">'Prognosis'</a> below.)</p><p>For patients with asymptomatic pulmonary KS, we typically initiate ART without concomitant chemotherapy. In some cases, however, treatment of KS with ART alone may be associated with a flare of the KS. For patients with symptomatic pulmonary KS or those with disease progression of pulmonary KS after initiation of ART, the addition of systemic chemotherapy to ART is indicated [<a href="#rid23">23-25</a>]. (See  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment", section on 'Immune reconstitution inflammatory syndrome'</a> and  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment", section on 'Treatment'</a>.)</p><p>For patients being treated with systemic glucocorticoids for another process (eg, Pneumocystis jirovecii pneumonia), discontinuation of glucocorticoids has been associated with regression of KS. (See  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment", section on 'Steroid reduction or withdrawal'</a>.)</p><p class="headingAnchor" id="H2892199"><span class="h2">Airway obstruction and bleeding</span><span class="headingEndMark"> — </span>Obstructive KS lesions of the upper airway are rare. Initial therapy is aimed at securing patency of the airway to achieve adequate ventilation and oxygenation. This may include endoscopic laser resection via rigid bronchoscopy, stent placement, and/or radiation therapy [<a href="#rid26">26-28</a>]. After establishing airway patency, systemic therapy with ART and chemotherapy is necessary to provide long term control of the KS. (See  <a class="medical medical_review" href="/d/html/4384.html" rel="external">"Clinical presentation, diagnostic evaluation, and management of malignant central airway obstruction in adults", section on 'Follow-up'</a> and  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment", section on 'Local symptomatic therapy'</a>.)</p><p>Hemoptysis due to tracheobronchial KS has been described only rarely; the optimal management is not known. Massive hemoptysis may require local therapy (eg, laser therapy, cryotherapy, balloon tamponade, topical <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>) to control bleeding and protect the airway. (See  <a class="medical medical_review" href="/d/html/4394.html" rel="external">"Evaluation and management of life-threatening hemoptysis"</a>.)</p><p class="headingAnchor" id="H23"><span class="h2">Pleural effusions</span><span class="headingEndMark"> — </span>The management of large pleural effusions due to KS can be difficult. We favor the use of repeated thoracentesis in combination with ART and chemotherapy rather than more upfront invasive procedures in this setting. If a pleural effusion recurs quickly (eg, in less than three weeks) despite repeated thoracentesis, an indwelling pleural catheter can be placed or <a class="drug drug_general" data-topicid="9496" href="/d/drug information/9496.html" rel="external">talc pleurodesis</a> can be performed, although experience with these therapies for pleural KS is limited [<a href="#rid29">29,30</a>]. (See  <a class="medical medical_review" href="/d/html/6700.html" rel="external">"Management of malignant pleural effusions"</a> and  <a class="medical medical_review" href="/d/html/6695.html" rel="external">"Chemical pleurodesis for the prevention of recurrent pleural effusion"</a>.)</p><p class="headingAnchor" id="H13609290"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Prior to the widespread introduction of ART, the presence of pulmonary KS was associated with a particularly poor prognosis, and the presence of visceral disease was incorporated into the AIDS Clinical Trials Group (ACTG) staging system [<a href="#rid31">31</a>]. Pulmonary KS is no longer associated with the same poor prognosis that it once had.</p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis and epidemiology</strong> – Kaposi sarcoma (KS) is a low-grade vascular tumor associated with human herpesvirus 8 (HHV-8). The incidence of KS has decreased markedly since the use of potent combination antiretroviral therapy (ART) became widespread. (See  <a class="medical medical_review" href="/d/html/8033.html" rel="external">"AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis", section on 'Epidemiology and risk factors'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Patients with pulmonary KS can present with shortness of breath, fever, cough, hemoptysis, or chest pain. In some cases, asymptomatic patients will have abnormalities on imaging as the only findings suggestive of pulmonary involvement.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Imaging findings</strong> – Two findings on chest computed tomography (CT) are highly suggestive of parenchymal KS: hilar densities extending into the parenchyma along peribronchovascular pathways and a characteristic septal or nodular pattern with concomitant pleural effusions. (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – The diagnosis of AIDS-related pulmonary KS is often clinical, typically based on the presence of mucocutaneous disease, compatible features on chest computed tomography, and endobronchial lesions characteristic of KS (when present)  (<a class="graphic graphic_picture graphicRef87393" href="/d/graphic/87393.html" rel="external">picture 5</a>). However, a detailed evaluation should exclude an infectious etiology or other tumors if any atypical features are present. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of pulmonary KS is broad and includes the full range of AIDS-associated infections and neoplasms that cause pulmonary symptoms developing over a few weeks. (See <a class="local">'Differential diagnosis'</a> above and  <a class="medical medical_review" href="/d/html/3721.html" rel="external">"Evaluation of pulmonary symptoms in persons with HIV"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic treatment</strong> – Patients living with HIV and pulmonary KS should receive treatment that includes antiretroviral therapy (ART). (See  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment", section on 'Treatment'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Asymptomatic pulmonary KS</strong> – For patients with asymptomatic pulmonary KS, we typically initiate ART without concomitant chemotherapy. In some cases, however, treatment of KS with ART alone may be associated with a flare of the KS. (See <a class="local">'Systemic treatment'</a> above and  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment", section on 'Combined antiretroviral therapy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptomatic pulmonary KS or progression on ART</strong> – For patients with symptomatic pulmonary KS or those with disease progression after initiation of ART, the addition of systemic chemotherapy to ART is indicated. Further details on the chemotherapy regimens used to treat AIDS-related KS are discussed separately. (See  <a class="medical medical_review" href="/d/html/8034.html" rel="external">"AIDS-related Kaposi sarcoma: Staging and treatment", section on 'Systemic therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment of</strong> <strong>endobronchial obstruction</strong> – In patients with symptomatic endobronchial obstruction due to KS, therapy is aimed at securing patency of the airway to achieve adequate ventilation and oxygenation. This may include endoscopic laser resection, stent placement, and/or radiation therapy. (See <a class="local">'Airway obstruction and bleeding'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment of pleural effusions</strong> – For patients with pleural effusions due to KS, we favor the use of repeated thoracentesis in combination with ART and chemotherapy rather than more upfront invasive procedures. If a pleural effusion recurs quickly (eg, in less than three weeks) despite repeated thoracentesis, an indwelling pleural catheter can be placed or <a class="drug drug_general" data-topicid="9496" href="/d/drug information/9496.html" rel="external">talc pleurodesis</a> performed, although experience in pleural KS is limited. (See <a class="local">'Pleural effusions'</a> above and  <a class="medical medical_review" href="/d/html/6700.html" rel="external">"Management of malignant pleural effusions", section on 'Expandable lung with rapid reaccumulation'</a>.)</p><p></p><p class="headingAnchor" id="H1905415098"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Talmadge King, Jr, MD, and Bruce J Dezube, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lodi S, Guiguet M, Costagliola D, et al. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst 2010; 102:784.</a></li><li><a class="nounderline abstract_t">Haramati LB, Wong J. Intrathoracic Kaposi's sarcoma in women with AIDS. Chest 2000; 117:410.</a></li><li><a class="nounderline abstract_t">Huang L, Schnapp LM, Gruden JF, et al. Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy. Am J Respir Crit Care Med 1996; 153:1385.</a></li><li><a class="nounderline abstract_t">Pinzone MR, Berretta M, Cacopardo B, Nunnari G. Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection. Semin Oncol 2015; 42:258.</a></li><li><a class="nounderline abstract_t">Joshi M, Markelova N, Palacio D, Schapira RM. A patient with HIV, dyspnea, and multiple pulmonary nodules: pulmonary Kaposi sarcoma. Chest 2006; 130:1924.</a></li><li><a class="nounderline abstract_t">Zibrak JD, Silvestri RC, Costello P, et al. Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory system. Chest 1986; 90:476.</a></li><li><a class="nounderline abstract_t">O'Brien, RF. Pulmonary and pleural Kaposi's sarcoma in AIDS. Semin Respir Med 1989; 10:12.</a></li><li><a class="nounderline abstract_t">Davis SD, Henschke CI, Chamides BK, Westcott JL. Intrathoracic Kaposi sarcoma in AIDS patients: radiographic-pathologic correlation. Radiology 1987; 163:495.</a></li><li><a class="nounderline abstract_t">Sivit CJ, Schwartz AM, Rockoff SD. Kaposi's sarcoma of the lung in AIDS: radiologic-pathologic analysis. AJR Am J Roentgenol 1987; 148:25.</a></li><li><a class="nounderline abstract_t">Garay SM, Belenko M, Fazzini E, Schinella R. Pulmonary manifestations of Kaposi's sarcoma. Chest 1987; 91:39.</a></li><li><a class="nounderline abstract_t">Miller RF, Tomlinson MC, Cottrill CP, et al. Bronchopulmonary Kaposi's sarcoma in patients with AIDS. Thorax 1992; 47:721.</a></li><li><a class="nounderline abstract_t">Meduri GU, Stover DE, Lee M, et al. Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical, radiographic, and pathologic manifestations. Am J Med 1986; 81:11.</a></li><li><a class="nounderline abstract_t">Roux FJ, Bancal C, Dombret MC, et al. Pulmonary Kaposi's sarcoma revealed by a solitary nodule in a patient with acquired immunodeficiency syndrome. Am J Respir Crit Care Med 1994; 149:1041.</a></li><li><a class="nounderline abstract_t">Nathan S, Vaghaiwalla R, Mohsenifar Z. Use of Nd:YAG laser in endobronchial Kaposi's sarcoma. Chest 1990; 98:1299.</a></li><li><a class="nounderline abstract_t">Wolff SD, Kuhlman JE, Fishman EK. Thoracic Kaposi sarcoma in AIDS: CT findings. J Comput Assist Tomogr 1993; 17:60.</a></li><li><a class="nounderline abstract_t">Hoskote SS, Patel VP. Pulmonary Kaposi sarcoma in AIDS. Mayo Clin Proc 2012; 87:e77.</a></li><li><a class="nounderline abstract_t">Gasparetto TD, Marchiori E, Lourenço S, et al. Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology. Orphanet J Rare Dis 2009; 4:18.</a></li><li><a class="nounderline abstract_t">Yoo DJ, Lee KH, Munderi P, et al. Clinical and bronchoscopic findings in Ugandans with pulmonary Kaposi's sarcoma. Korean J Intern Med 2005; 20:290.</a></li><li><a class="nounderline abstract_t">Kaplan LD, Hopewell PC, Jaffe H, et al. Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1988; 1:23.</a></li><li><a class="nounderline abstract_t">Aboulafia DM. The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest 2000; 117:1128.</a></li><li><a class="nounderline abstract_t">Gill PS, Akil B, Colletti P, et al. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med 1989; 87:57.</a></li><li><a class="nounderline abstract_t">Cadranel JL, Kammoun S, Chevret S, et al. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax 1994; 49:958.</a></li><li><a class="nounderline abstract_t">Dittmer DP, Richards KL, Damania B. Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers. Front Microbiol 2012; 3:141.</a></li><li><a class="nounderline abstract_t">Mosam A, Shaik F, Uldrick TS, et al. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr 2012; 60:150.</a></li><li><a class="nounderline abstract_t">Sigel K, Pitts R, Crothers K. Lung Malignancies in HIV Infection. Semin Respir Crit Care Med 2016; 37:267.</a></li><li><a class="nounderline abstract_t">Belda J, Canalís E, Gimferrer JM, et al. Subglottic stenosis in an HIV positive patient: an exceptional form of clinical presentation in Kaposi's sarcoma. Eur J Cardiothorac Surg 1997; 11:191.</a></li><li><a class="nounderline abstract_t">Lawson G, Matar N, Kesch S, et al. Laryngeal Kaposi sarcoma: case report and literature review. B-ENT 2010; 6:285.</a></li><li><a class="nounderline abstract_t">Miner JE, Egan TD. An AIDS-associated cause of the difficult airway: supraglottic Kaposi's sarcoma. Anesth Analg 2000; 90:1223.</a></li><li><a class="nounderline abstract_t">O'Brien RF, Cohn DL. Serosanguineous pleural effusions in AIDS-associated Kaposi's sarcoma. Chest 1989; 96:460.</a></li><li><a class="nounderline abstract_t">Rubio ER, Chang EE, Kovitz KL. Thoracoscopic management of pleural effusions in Kaposi's sarcoma: a rapid and effective alternative for diagnosis and treatment. South Med J 2002; 95:919.</a></li><li><a class="nounderline abstract_t">Nasti G, Talamini R, Antinori A, et al. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals. J Clin Oncol 2003; 21:2876.</a></li></ol></div><div id="topicVersionRevision">Topic 4326 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20442214" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10669683" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Intrathoracic Kaposi's sarcoma in women with AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8616570" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25843730" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17167017" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A patient with HIV, dyspnea, and multiple pulmonary nodules: pulmonary Kaposi sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3489584" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pulmonary and pleural Kaposi's sarcoma in AIDS</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3562832" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Intrathoracic Kaposi sarcoma in AIDS patients: radiographic-pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3491519" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Kaposi's sarcoma of the lung in AIDS: radiologic-pathologic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3792084" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pulmonary manifestations of Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1440467" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Bronchopulmonary Kaposi's sarcoma in patients with AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3728535" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical, radiographic, and pathologic manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8143039" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pulmonary Kaposi's sarcoma revealed by a solitary nodule in a patient with acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2225991" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Use of Nd:YAG laser in endobronchial Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8419441" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Thoracic Kaposi sarcoma in AIDS: CT findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23036685" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pulmonary Kaposi sarcoma in AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19602252" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16491826" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical and bronchoscopic findings in Ugandans with pulmonary Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3265151" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10767252" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2472743" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Pulmonary Kaposi's sarcoma: clinical findings and results of therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7526480" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22529843" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22395672" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26974303" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Lung Malignancies in HIV Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9030811" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Subglottic stenosis in an HIV positive patient: an exceptional form of clinical presentation in Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21302692" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Laryngeal Kaposi sarcoma: case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10781485" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : An AIDS-associated cause of the difficult airway: supraglottic Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2766805" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Serosanguineous pleural effusions in AIDS-associated Kaposi's sarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12190232" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Thoracoscopic management of pleural effusions in Kaposi's sarcoma: a rapid and effective alternative for diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12885804" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
